Presented by
Management Forum
The Pharma Mini MBA Training Course
A three-day accelerated management programme to give you the high-performance management skills of an MBA, designed specifically for pharmaceutical/biotechnology professionals and also applicable to medical device/animal health industries
★★★★★ "I wanted to get a grasp of how a real MBA would look like and learn the tools that are used the most... more (51)"
6-8 November 2024
+ 19-21 March 2025, 9-11 July 2025, 5-7 November 2025 »
from £1199
- Format: Live online
- CPD: 18 hours for your records
- Certificate of completion
Course overview
Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This event has been especially designed to help you transcend these challenges by training you to become equipped to see the bigger picture in all aspects of your role. It will help you build your management skills for the future and prepare you to fulfil your ambitions.
The Pharma Mini MBA accelerated management programme is a distillation of the most valuable parts of an MBA, as applied to the pharmaceutical industry. It will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with pharmaceutical case studies from business schools.
Pharmaceutical industry context – business school pharmaceutical case studies on each module
This intensive three-day course will help you to translate your learning into new behaviours and improvements in your capability and performance and will work through live issues impacting on the industry and on you directly. The individual and group exercises will focus on pharmaceutical/biopharma/generic MBA case studies, and also on your own challenges and examples. The business school case studies will help give the ‘feel’ of a full MBA and help you understand more about the strategies used in today’s pharmaceutical and associated industries.
The Pharma Mini MBA is also an invaluable guide to all that is best and most practical on an MBA course – with specific focus on the pharmaceutical sector. It is also of value either to gain the most useful aspects of an MBA or as an MBA taster, providing a foundation of the essential MBA elements to apply directly to your role. The pharmaceutical industry requires employees to focus on successful leadership and business management skills, which this programme is designed to give you.
This training course is part of our collection of Leadership & Management Training Courses which focus on leadership, innovation, strategy, communication, finance, problem solving and conflict management, to name a few key areas.
Key benefits of attending
MBA learning style of the programme
The Pharma Mini MBA learning style is ‘hands-on’ rather than academic. The programme is very practical, without being too theoretical, with industry-relevant case studies drawn from business school cases. The course covers the key areas of an MBA and applies these MBA tools and concepts to the pharmaceutical industry, providing you with a firm foundation of the essential MBA thinking and terminology. Three modules will be covered in just three days of interactive workshops to enhance the value of the course and, to minimise your time away from the office, there is also optional pre- and post-course work set by the programme director.
- Develop your understanding of the key techniques of an MBA to apply to your work
- Gain a greater understanding of the pharma industry, its drivers, challenges and opportunities
- Hear about the latest strategic technology innovations being used and developed in the pharma industry
- Understand what strategic thinking is and how to use strategy tools
- Develop your leadership and strategic skills
- Become more effective in coping with and managing change in the pharma industry
- Explore the benefits and costs of doing an MBA
- Take away a Mini MBA toolkit to apply to your job
- Discuss and learn from real pharma industry case studies
Pre-course work (sent out to delegates prior to the course)
- Diagnostic questionnaire – your strategic competencies
- Discussions of diagnostic output/other areas of value
Who should attend?
A ‘must-attend’ for professionals in the pharmaceutical/biopharma/medical device/animal health industries wishing to develop their business management skills for more senior levels and beyond mere technical ability. It will also help anyone thinking of studying for an MBA who would like an idea of what is involved. It is particularly beneficial to attend with a colleague to maximise the practical learning.
This course will cover:
Strategy and strategic challenges in the pharma industry
- Strategy and strategic thinking and their importance in the pharma industry
- Strategic analysis, planning and implementation
- Environmental analysis
- Understanding the competitive environment
- Strategic options
- Applying the MBA toolkit
- Stakeholders and their expectations in the pharma industry
- Obtaining the value out of strategy in the pharma industry
Commercial management and leadership in the pharma industry
- New product development and the target product profile
- Portfolio management used in the pharma industry
- Understanding business performance
- The business plan
- Diagnosing specific performance problems
- Developing strategic alliances and collaborations in the pharma industry
- Benefits, costs of doing an MBA and the different routes
- The role of leadership
- What are the core competencies of effective leaders in pharma?
- Leadership vs management
- Leadership style and approaches in the pharma industry
Managing innovation in the pharma industry
- Innovation approaches currently being adopted along the pharma value chain
- Future innovations in pharma and the life science industries
Hot topics in market access strategy
Leading and implementing pharma strategy and change
- Leading successful change
- Diagnosis around change
- How to create the conditions for successful change
- Why people resist change and how to manage this
- Change management including leading a structural reorganisation
- Creating a team, department and organisation relevant to today’s pharma business needs
- Team formation and development
- Implementing strategy and change, essentials of planning and managing projects
- Project management tools and techniques to use in implementing pharma projects
- Applying key project management techniques to pharma projects
- Understanding of cultural awareness to work more effectively with pharma colleagues
Practical application/review
- Personal development action plan to apply the learning within your own organisation
- Revisiting your competency assessment – what has shifted?
- Recommended further reading
- Practical application of tools (toolkit)
Laura Brown
Independent Pharmaceutical Consultant
Dr Laura Brown MBA, BSc (Biochemistry), BSc (Psychology), PhD, Diploma in Clinical Science, FICR, is Chair of an international pharmaceutical management consultancy and course director and senior lecturer for the MSc in Clinical Research at the School of Pharmacy, University of Cardiff. She has also worked as an associate with Cranfield School of Management on the leadership module of the MBA programme and their strategic thinking courses.
Dr Brown worked for Cambridge Corporate Development, an international strategy consultancy, for seven years and has extensive experience in senior management roles in the pharmaceutical industry. She has worked for Wellcome, Hoechst Marion Roussel and Phoenix International and consulted internationally with numerous pharmaceutical companies in the EU, US, Singapore, China and India. She is co-author of several management books including Be Your Own Strategy Consultant, The Ultimate Book of Business Skills and Project Management for the Pharmaceutical Industry.
Leela Barham
Leela Barham Economics Consulting Ltd
Leela Barham is a freelancer with a background in health economics and now works in academia, as a journalist and with all stakeholders in the health care system conducting research on the economics of health and pharmaceuticals. She has over 20 years of experience and has been published in both peer reviewed journals and the specialist pharmaceutical press. She also worked to support the UK government as it agreed the 2019 voluntary scheme for branded medicines pricing and access.
Oguz Ozden
PWC
Oguz is a strategy consultant in PwC’s Strategy& practice, leading large, complex and international transformations across the Pharma and Life Sciences sector. He has over 10 years of consulting experience in the sector having worked across various functions in Biotech, Pharma and Consumer Health as well as Pharmaceutical Wholesale.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
- 30% off the 2nd delegate*
- 40% off the 3rd delegate*
- 50% off the 4th delegate*
Please contact us for pricing if you are interested in booking 5 or more delegates
6-8 November 2024
Live online
09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 14015
- GBP 1,199 1,499
- EUR 1,729 2,149
- USD 1,981 2,449
Until 02 Oct
- 3 days live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
19-21 March 2025
Live online
09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
05:30-13:00 New York (UTC-04)
Course code 14490
- GBP 1,199 1,499
- EUR 1,729 2,149
- USD 1,981 2,449
Until 12 Feb
- 3 days live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
9-11 July 2025
Live online
09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 14882
- GBP 1,199 1,499
- EUR 1,729 2,149
- USD 1,981 2,449
Until 04 Jun
- 3 days live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
5-7 November 2025
Live online
09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 15044
- GBP 1,199 1,499
- EUR 1,729 2,149
- USD 1,981 2,449
Until 01 Oct
- 3 days live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
Reviews of IPI's The Pharma Mini MBA training course
I wanted to get a grasp of how a real MBA would look like and learn the tools that are used the most for taking strategic decisions in the pharma industry. I have achieved this skills fully and got a good picture of strategic thinking in the pharma industry.
I also wanted to learn more about leadership and strategic thinking and I think this was also covered.
May 15 2024
Çiğdem ÖZTÜRK ÖZOLUR 
International Market Senior Regulatory Affairs Specialist, Recordati İlaç San. ve Tic. A.Ş.
Nov 8 2023
I wanted to get a grasp of how a real MBA would look like and learn the tools that are used the most for taking strategic decisions in the pharma industry. I have achieved this skills fully and got a good picture of strategic thinking in the pharma industry. Good service overall and communications
Jordi Fina 
Senior Research Associate, Evox Therapeutics Ltd
Feb 8 2023
It was very good for a 3-day program
Cheron Palmer 
Managed Markets Director, Medexus
Nov 9 2022
I was expecting to get more awareness of what a full MBA would be like and I achieved this. I also wanted to learn more about leadership and strategic thinking and I think this was also covered.
Pablo Sancho
EU Manager – Global Monitoring, Incyte
May 18 2022
Hopes: An introduction to business management concepts unfamiliar to me. Achieved? Absolutely. Laura Brown was an absolutely fantastic and highly engaging speaker over the three days of the course. One of the best courses I have attended and would highly recommend to my colleagues.
Saadia Basharat
Senior Consultant, Alacrita Consulting Ltd
Feb 7 2022
Great course, especially if you are looking to opt for an actual MBA, this is a good taster
Lana George
Portfolio Manager, Roche Product Ltd
Nov 9 2022
I was hoping to have a better overview of what an MBA is, and if this is something beneficial for me in the near future. Also which techniques and tools can I use in my daily tasks at work just by taking the Mini MBA. I have accomplished this.
Jorge Flores 
Regulatory Professional, Novo Nordisk A/S
Nov 9 2022
Well thought out and very relevant
Sarah Bunyan
Associate Director - Regulatory Affairs, Medical Devices & CMC, Vectura
May 18 2022
I thought it was well structured and well delivered.
Anthonia Oluwatuyi
Quality Graduate, Bespak Europe Limited
Feb 7 2022
I had hoped for a recap of the various strategies and tools, and got exactly that, thanks. It was useful to talk about the MBA in general too.
Mia Rensch-Jacobsen
Sr. Outsourcing Professional , Novo Nordisk A/S
Feb 7 2022
I hoped to improve my strategic thinking skills and my understanding of how business/project decisions are made and executed. While such skills and understanding are obviously not improved overnight, I certainly feel that I have learnt a lot and been equipped with tools that will help me achieve those goals. I aim to continue looking at the course material and practice some of the tools in my work.
Lillian Sandø
Principal Medical Writer, LEO Pharma A/S
Nov 10 2021
The content was interesting and explained from the pharma field perspective.
Daria Dziura 
Project Trainee, Tjoapack Netherlands B.V.
May 12 2021
Great course, enjoyed it a lot, would recommend.
Andrei Ilie
Doctor, NHS
May 12 2021
The course greatly matched my expectations and it was an invaluable experience, enriching my understanding and providing me with a toolkit to work on in my career.
Vasileios Eftychidis
Knowledge Transfer Associate - NeuroOncology, Cardiff University
May 12 2021
Very good I enjoyed it, right amount of time and info delivered. Very good interaction with the speakers and all the participants who were from very various backgrounds.
Eric Helmer
Director Clinical Pharmacology, Galapagos
May 12 2021
I've really enjoyed this webinar, covering all I was looking for in a short amount of time while keeping it very interesting and interactive along the way. Laura was very impressive, going through a lot of material and always keeping it very interesting. Case studies were very interesting. I also appreciated the use of different interactive tools for exercises.
Audrey Dicaire-Lavigne 
Pharmacovigilance Leader, Jubilant Draximage Inc.
Nov 11 2020
I expected to be given the opportunity to strengthen my understanding of the pharma industry and key strategies for product development. I am happy to confirm this program allowed to do so!
Tiphaine Lamblot 
Clinical Operations Leader, Clinical Operations, SANTEN
Nov 11 2020
Great course. Intense but good opportunity to learn and well presented. I enjoyed he group work and chatting to everyone too.
Feargal Cosgrove
Licensing Manager – Research & Impact, University of Ulster
Nov 11 2020
Very good, good set of strategic analysis tools was given..
Andreas Gallei 
Head of Swine Virology, BIVRC GmbH & Co KG
Nov 11 2020
The guest speakers were a good addition. Overall, well done.
Katie Sippel
Director, Quality Compliance, Novocol Pharmaceutical of Canada Inc.
Nov 4 2019
Overall it was a very interesting course with much knowledge and very useful techniques for strategic thinking. I really enjoyed the case studies and working in teams to accomplish the exercises. Very well done and very well organised.
Theofanis Mantourlias 
Senior Manager Formulation Development, Fresenius Kabi Austria GmbH
May 14 2019
Course very useful to get an overview of what a MBA could be. Laura makes the course very interactive and really interesting with many real life examples. Her knowledge of the global pharma industry is quite impressive.
Camille Rivail
Senior Manager Business Development, Avadel Pharmaceuticals SA
May 14 2019
Thank you for a great learning experience!
Jasper Deuring
Medical Affairs , Pfizer
Nov 5 2018
For a 3 day course, we covered a good spread of techniques and information. Having the talks sparked thoughts and also provided a change of pace. The speakers were excellent and Laura's energy & experience was very much appreciated.
Lorraine Borland
Director, Strategic Projects, Sartorius-Stedim BioOutsource
Nov 5 2018
The course gave a real insight into the MBA. There were so many tools I could take back with me and apply to my working life not only for myself , but for my colleagues. The course was a great mix of theory, case studies, external talks and media. Laura was extremely knowledgeable with great credibility within the industry. The course has made me consider a full MBA and also exploring what other courses have Laura as the trainer.
Emma Lennon
Group Manager, GW Pharmaceuticals
May 14 2018
Great energy. Best training I had in a long time.
Florent Noel 
Sr Manager QA, Covis Pharma
May 14 2018
Laura [was] very engaging, varied content, good level, Not one boring moment! Deming [offered a] good practical experience in pharma. Great to have had a chance to practically use the tools Laura recommended.
Emma Dupree
RDQA Global Director AREA , AbbVie Ltd
Nov 5 2018
Laura Brown is a very interesting speaker
Mehdi Sellami 
Scientific Director, Laboratoires Galpharma
Nov 5 2018
I think this was a very useful, practical and interesting course. I was able to adopt a strategic thinking that I will be able to implement in my work.
Aintzane Garcia 
Medical Department, Faes Farma SA
Nov 5 2018
Good coverage of wide topic area, extremely useful for someone from a single function to get wider overview
Mark Andrews
Technical Director / QP, Deputy Managing Director, Torbay and South Devon NHS Foundation Trust
Nov 1 2017
Really good overview and opportunity to ask many questions. Great course.
Luisa Teixeira
Account Manager, Owen Mumford Ltd
Nov 1 2017
Laura is a very dynamic person that knows very well how to deliver a message. The topics are very interesting from the pharma/management point of view and articulated - Would be interesting to have topic about pharma at geographical level
Janneth Ospina Paladines
Senior Regulatory Affairs Associate, Gilead Sciences International
Nov 1 2017
Very interesting
Emine Akin 
Marketing & Sales Junior Assistant, Chiesi Group
Nov 1 2017
Overall good, too little time!
Janni Hermansen
Senior PV Advisor, LEO Pharma
May 22 2017
Course was very condensed either reduce the content or extend the course days
Aziz-ul-Islam Chaudhry
Head of Regulatory Affairs, Martindale Pharma
May 22 2017
I found it really practical, lively with possibility to exchange experiences
Mireille Pierrevelcin
Export Area Manager, Cesra Arzneimittel GmbH & Co
May 22 2017
The course is very good. Gives you in three days an overall view on core subjects that management people need to know to improve. Case studies were excellent and realistic. Speakers were great
Diana Binkert
Acino International AG
Nov 28 2016
Excellent. Thoroughly enjoyed it and left feeling like I had learnt something, which, at the end of the day, is the primary goal. I appreciated the method of teaching and enjoyed meeting other people on the course.
Zain Masters
Business Development & Licensing Director, Masters Speciality Pharma
Nov 28 2016
It was a very nice overview on MBA topics overview on MBA topics with a great speaker and interesting discussions
Ricarda Tiemeyer
Drug Safety Scientist & Deputy LSR, Roche Pharma (Switzerland) AG
Nov 28 2016
It exceeded my expectations. Really enjoyed practical sessions and focused environment.
Andriy Kirmach
Associate Director, International Compliance & Ethics, Allergan
Nov 28 2016
Overall excellent course, very well organized. Suitable content, stimulating presentations and excellent speakers.
Suna Horner
Associate Medical Manager, HRA Pharma UK & Ireland Ltd
May 18 2016
It was very informative and engaging with real potential to help with daily practicalities. The full content and delivery is hitting the mark in my opinion.
Irem Bostanci
Account Manager OEM, Owen Mumford Ltd
May 18 2016
Perfect blend of theory and practicality that allowed the attendees to process and apply the information to real world scenarios. Extremely valuable taster into the world and benefits of an MBA!
Dave Wood
Account Director, PharmiWeb Solutions
May 18 2016
An excellent course. I would recommend to all wanting a flavour of an MBA.
Bindu Patel
Senior Manager , Sanofi Pasteur MSD
May 18 2016
Good
Kevin Polhill
Quality and Regulatory Compliance Specialist, Invicta Compliance
May 18 2016
Excellent trainer, lots of info in a short time but actually by the end I thought it was a suitable duration and speed. Would have been nicer to have a little more on the PM part at the end simply because that fits better with my role.
Julia Caldwell
Clinical Trial Manager, Allergan
May 18 2016
This was a well-organised course and both the content and speakers were very good. I do think that the topics could have been tied together better in some instances in the same way as the strategy tools we covered. Some elements such as project management were covered far too quickly to be of any use.
Emma Woods
Pharmaceutical Development Innovation Lead, AstraZeneca Pharmaceuticals Development
May 18 2016
Good mix of people and perspectives; venue was easy to get to. Guest speakers were a good idea.
Julie-Anne Webb
Inside Sales Associate - EU, Core Informatics
May 18 2016
It was rushed in places with things being skipped over - its good to try and include a lot but not if its skipped...doesn't help
GEOF WOLFENDEN
IP & Contracts Manager, AstraZeneca
Nov 28 2016
Provided exactly what I required
Peter Gaines
Chief Medical Officer, Veryan Medical Limited
May 18 2016
Few topics to develop
Edmondo Corona 
Plan Engineering Director, AbbVie
United Kingdom
- 4D Pharma PLC
- AbbVie Ltd
- Aesica Queenborough Limited
- Alacrita Consulting Ltd
- Alander Consulting Limited
- Allergan
- Allergan UK Limited
- Amersham Hospital
- Amicus Therapeutics UK Limited
- Antisoma Research Ltd
- Arecor Limited
- ARROW THERAPEUTICS LTD
- AstraZeneca
- AstraZeneca Pharmaceuticals Development
- AstraZeneca Plc
- AstraZeneca R&D Charnwood
- BAUSCH & LOMB INC
- Bayer Healthcare
- Bespak Europe Limited
- Biogen
- Biogen Idec
- Biogen IDEC Ltd
- Biogen Idec Ltd., UK
- Biogen Ltd
- BioMarin International
- BlueReg
- Boehringer Ingelheim
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Britannia Pharmaceuticals Ltd.
- BTG International Ltd
- Cardiff University
- Celgene Europe Limited a Bristol Myers Squibb Company
- Celgene Europe Ltd
- Chiesi Ltd
- Christina carnegie Consultancy
- Chugai Pharma Europe Ltd
- Clinigen Healthcare Ltd
- ConvaTec UK Ltd
- Dechra Veterinary Products
- Eisai Limited
- Eisai Ltd
- Eisai Manufacturing Limited
- Eli Lilly & Co Ltd
- Evox Therapeutics Ltd
- Fujifilm Kyowa Kirin Biologics
- G-Pharm Ltd
- Galapagos
- Galen Ltd
- Genzyme Therapeutics Ltd
- Gilead Sciences International
- Gilead Sciences International Limited
- GlaxoSmithKline
- GSK
- GW Pharmaceuticals
- GW PHARMACEUTICALS PLC
- Hospira UK Limited
- HRA Pharma UK & Ireland Ltd
- Incyte
- Indivior PharmaceuticalUK Ltd
- Indivior UK Limited
- Intercept Pharma Europe Ltd
- Intercept Pharmaceuticals
- Invicta Compliance
- Janssen
- Janssen Cilag Ltd
- Johnson & Johnson
- Johnson & Johnson Consumer Services EAME Ltd
- Johnson & Johnson Limited
- KINGSTON UNIVERSITY
- LifeScientific
- Martindale Pharma
- Masters Speciality Pharma
- Medimmune UK Limited
- Medipro Consulting Ltd
- MEDIS LIMITED
- Merck Sharp & Dohme Ltd
- Mitsubishi Tanabe Pharma Europe Ltd
- MSD Animal Health
- Mylan
- NDA Regulatory Science Ltd
- NHS
- Nordic Pharma
- NOVARTIS VACCINES
- Owen Mumford Ltd
- Parexel International
- Pathway Intermediates
- Pfizer
- Pfizer Limited
- PharmArchitecture Limited
- PharmiWeb Solutions
- PRA International Ltd
- Prostrakan Group Ltd
- PROTHERICS PLC
- Quotient Clinical Ltd
- R + D DIRECTORATE NHS GRAMPIAN
- Recipharm
- Reckitt Benckiser Health Care (UK) Ltd
- Reckitt Benckiser Healthcare (UK) Ltd
- Reckitt Benckiser International Limited
- Red Line Pharmacovigilance
- Red Line Pharmacovigilance Ltd
- Regulink Ltd
- ROCHE
- Roche Product Ltd
- Rosemont Pharma Ltd
- Sales-Link, Inc.
- Sanofi Pasteur MSD
- Sanofi-Aventis
- Sartorius-Stedim BioOutsource
- SCHWARZ PHARMA Limited
- Scottish National Blood Transfusion Service
- Shire Pharmaceutical Ltd
- SI Associates Ltd
- Stiefel Labs (Maidenhead) Ltd
- Strategic Consultants
- Strathclyde Institute of Pharmacy and Biomedical Sciences
- Takeda
- Takeda Development Centre Europe Ltd
- Takeda UK
- Takeda UK Ltd
- TEVA UK
- Thomson Reuters
- Thornton & Ross Ltd
- Toray Industries Inc
- Torbay and South Devon NHS Foundation Trust
- Torbay Pharmaceuticals
- UCB
- UCB Pharma Limited
- UCB Pharma Ltd
- United Therapeutics Europe Ltd
- UNIVERSITY OF CARDIFF
- University of Strathclyde
- University of Ulster
- Vantia Limited
- Vectura
- Vectura Group plc
- Vertex Pharmaceuticals (Europe) Limited
- Veryan Medical Limited
- Vifor Pharma UK Ltd
- Waymade Healthcare plc
- Winthrop Pharmaceuticals UK Ltd
- Wyeth Europa Ltd
Germany
- ABBOTT GmbH & Co KG
- Bayer AG
- Bayer Aktiengesellschaft
- Bayer Animal Health GmbH
- Bayer Healthcare
- Bayer Healthcare AG
- Bayer Pharma AG
- BIVRC GmbH & Co KG
- Boehringer Ingelheim Veterinary Research Center GmbH & Co. KG
- Boehringer Ingelheim Vetmedica GmbH
- Boehringer Ingelheim VRC GmbH & Co. KG
- Cesra Arzneimittel GmbH & Co
- Cheplapharm
- Cheplapharm Arzneimittel GmbH
- Grunenthal GmbH
- HEUMANN PHARMA GMBH & CO
- Life Molecular Imaging GmbH
- Medac GmbH
- Merck Kg A.a.
- Merck KGaA
- Mundipharma Deutschland GmbH & Co KG
- Nordmark Arzeneimittel GmbH & Co KG
- Pieris Pharmaceuticals GmbH
- Sandoz International GmbH
- SCIL TECHNOLOGY GmbH
- Semigator GmbH
- Takeda GmbH
Switzerland
- Vifor Pharma AG
- Acino International AG
- Alvotech Swiss AG
- Amgen (Europe) GmbH
- Ares Trading SA
- BeiGene Switzerland
- Covis Pharma
- Covis Pharma BV
- Crucell Switzerland AG
- Elanco Animal Health
- F. Hoffmann-La Roche Ltd
- FISHER CLINICAL SERVICES GmbH
- Helsinn Healthcare S.A.
- IBSA Institut Biochimique SA
- Lundbeck (Schweiz) AG
- Merck Serono SA
- Novartis Vaccines & Diagnostics AG
- Novo Nordisk
- Octapharma AG
- Roche Pharma (Switzerland) AG
- Santen SA
- SERONO INTERNATIONAL SA
- Serono Pharma International
- SkyePharma AG
- Takeda Pharmaceuticals International AG
- Takeda Pharmaceuticals International GmbH
- Vifor Pharma AG
Denmark
- Albumedix Ltd
- ALK
- Alk Abello A/S
- Boehringer-Ingelheim Danmark A/S
- Coloplast A/S
- Dako Denmark A/S
- DANISH CANCER SOCIETY
- Ferring Pharmaceuticals A/S
- Genmab AS
- LEO Pharma
- LEO Pharma A/S
- MERCK SHARP & DOHME
- Merial Norden A/S
- Neurosearch A/S
- Novo Nordisk
- Novo Nordisk A/S
- Novo Nordisk AS
- Novo Nordisk Scandinavia
- NovoNordisk A/S
- Takeda Pharma A/S
- Xellia Pharmaceuticals ApS
France
- IPSEN INNOVATION
- Aeras Global TB Vaccine Foundation
- Astrazeneca
- Avadel Pharmaceuticals SA
- Baxter SAS
- Boehringer Ingelheim Animal Health France
- GALDERMA R & D
- Ipsen Consumer Healthcare SAS
- IPSEN INNOVATION
- Ipsen Pharma SAS
- Laboratoires Fournier
- LFB Biomedicaments
- MEDINCELL
- Sanofi-aventis
- SANTEN
- Teva Sante
- Wyeth Pharmaceuticals
Netherlands
- Abbott Biologicals BV
- Abbott Healthcare Products BV
- Abbott Vascular B.V.
- Amgen Europe BV
- Astellas Pharma Europe B.V.
- Astellas Pharma Europe BV
- BIOGEN IDEC BV
- DADA Consultancy
- FERRING BV
- Merck Sharp & Dohme
- Merus NV
- Pfizer
- Prothya
- Sanquin Plasma Products B.V.
- Seqirus
- Sun Pharma
- Tjoapack Netherlands B.V.
Belgium
- Aratana Therapeutics NV
- Chiesi Group
- Cyberonics Europe BVBA
- Fujirebio-Europe NV
- Galapagos NV
- Glaxo Smithkline Biologicals
- Janssen Infectious Diseases - Diagnostics BVBA
- Janssen Pharmaceutica NV
- Ortho Biotech, Johnson & Johnson
- UCB Pharma SA
- VIB
- ViroVet BVBA
Austria
- Baxter Innovations GmbH
- Eli Lilly Regional Operations GmbH
- Fresenius Kabi Austria GmbH
- MED-EL Elektromedizinische Geräte GmbH
- Octapharma Pharmazeutika Produktionsges.m.b.H.
- Takeda/Baxalta
- Valneva Austria GmbH
Ireland
- Alexion Pharmaceuticals
- Alkermes
- Alkermes Pharma Ireland Ltd
- ENTERPRISE IRELAND
- Pfizer Limited
- Shire Pharmaceuticals Ireland Ltd
Italy
- AbbVie
- Chiesi Farmaceutical SpA
- Chiron S.r.l
- GlaxoSmithKline Vaccines & Diagnostics s.r.l.
- Menarini Ricerche Spa
- Zambon Company SpA
Spain
- ALMIRALL, S.A.
- Centro de Investigacion Farmaceutica
- Chemo Espana SL
- Faes Farma SA
- Laboratorios Leti SL Unipersonal
- PHARMACEUTICAL RESEARCH ASSOCIATES
Croatia
- Agencije Za Lijekove I Medicinske Proizvode
- Belupo d.d.
- Europharma doo
- EWOPHARMA d.o.o.
- Pliva - Research & Development Ltd
Poland
- GSK
- PHYTOPHARM KLEKA SA
- POLPHARMA GROUP
- Polpharma SA
- Radiometer Sp. z o.o.
Sweden
- Astra Zeneca AB
- LEO Pharma
- Orexo AB
- OTSUKA PHARMA SCANDINAVIA AB
- Wellspect Healthcare
Canada
- GSK Biologicals
- Jubilant Draximage Inc.
- LAURENENTIAN UNIVERSITY
- Novocol Pharmaceutical of Canada Inc.
United States of America
- Core Informatics
- Genmab AS
- Medexus
- TITAN PHARMACEUTICALS INC
Egypt
- Minapharm Pharmaceuticals
- Rhein-Minapharm Biogenetics
- Zoetis
Finland
- Orion Corporation Orion Pharma
- Orion Oyj Orion Pharma
- Orion Pharma
Kuwait
- Al Hafez Trading Est
- Gharghour Arabian Gulf Co. w.I.I.
- Yiaco Medical Co
Czech Republic
- Cayman Pharma s.r.o.
- Pro-Med CS Praha AS
Norway
- Novo Nordisk AS
- Pronova BioPharma
Portugal
- BIAL - PORTELA & CA, S.A.
- JABA FARMACEUTICA S.A
Saudi Arabia
- Avalon Pharma
- Saudi Food and Drug Authority
Turkey
- BOEHRINGER INGELHEIM
- Recordati İlaç San. ve Tic. A.Ş.
United Arab Emirates
- Hospira (ME & NA)
- Newbridge Pharmaceuticals
Australia
- Elanco
Bulgaria
- ASSOCIATION OF BULGARIAN
Ecuador
- Grunenthal
Georgia
- GEOPHARMA LIMITED
Iceland
- Actavis Group PTC ehf.
India
- MAK COLLEGE OF PHARMACY AND MAK LABS
Israel
- Compugen Limited
Jordan
- Pharma International Co - PIC
Lithuania
- UAB GLAXOSMITHKLINE LIETUVA
Nigeria
- Link Health Care Pharmacy Nigeria Limited
Romania
- Arriello Group
Russia
- Association of Clinical Trials Organizations
South Africa
- AstraZeneca South Africa (Pty) Ltd
Tunisia
- Laboratoires Galpharma
Yemen
- Ibn Hayyan & Mohdar Co (Eisai Co Ltd)
Run The Pharma Mini MBA Live online for your team
4 days
Typical duration
Pricing from:
- GBP 1,400
- Per attendee, based on 10 attendees
- Course tailored to your requirements
- At your choice of location, or online
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:
